# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 104

Extent: E+W+S+N.I.

In regulation 136 (amendment of regulation 169 (mixing of general sale medicinal products)), for “insert “ UK ” before “marketing authorisation” ” substitute “for “marketing authorisation” substitute “ UK marketing authorisation or EU marketing authorisation ””.

---
Source: https://www.legislation.gov.uk/uksi/2020/1488/schedule/2/paragraph/104 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-104
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.